Author:
Meunier Pierre J.,Ravault Alain
Reference56 articles.
1. Alexandre C, Chapuy MC, Bressot C, et al: Traitement de la maladie osseuse de Paget par l’ethanc-1-hydroxy-1, diphosphonate à faible posologic. Nouv Presse Med 1980; 9: 3429–3433.
2. Alexandre C,Chapuy MC, Vignon E, et al: Treatment of Paget’s disease of bone with ethane-1-hydroxy-1, 1-diphosphonate (EHDP) at a low dosage (5 mg/kg/day). Clin Orthop 1983; 174: 193–205.
3. Altman RD, Johnston CC, Khairi MRA, et al: Influence of disodium etidronate on clinical and laboratory manifestations of Paget’s disease of bone (osteitis deformans). N Engl J Med 1973; 189: 1379–1384.
4. Canfield RE, Rosner W, Skinner J, et al: Diphosphonate therapy of Paget’s disease of bone. J Clin Endocrinol Metab 1977; 44: 96–106.
5. Devries HR, Bijvoet OLM: Results of prolonged therapy with EHDP in Paget’s disease. Neth J Med 1974; 17: 281–298.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The evaluation and treatment of Paget's disease of bone;Best Practice & Research Clinical Rheumatology;2020-06
2. Paget’s Disease of Bone: Pathogenesis and Treatment;Bone-Metabolic Functions and Modulators;2012